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Background
Eosinophilic Esophagitis (EoE) is a disease in children
characterized by esophageal dysfunction and eosinophilic
infiltration [1]. Patients frequently present with an atopic
history; therefore, allergy testing by both skin prick and
food patch testing are often performed. However, the
utility of allergy testing remains unclear [1,3]. Treatment
with topical corticosteroids may be needed for clinical
and histologic improvement if allergic triggers are not
identified [1,2]. However, the natural history of EoE
suggests that this condition is chronic and may recur
when corticosteroids are withdrawn [2]. Therefore, treat-
ment with dietary/aeroallergen avoidance is preferable to
reduce the need for oral corticosteroids, while preventing
exacerbation of EoE [3]. This study aims to describe the
atopic characteristics of a pediatric cohort with EoE over
a 10 year period at a tertiary care center.
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Figure 1 (N=69) underwent skin prick testing
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Methods
All children (< 18 years) who had esophagogastroduode-
noscopy with biopsy proven EoE (15+ eosinophils per high
power field) at McMaster Children’s Hospital between
January 2003 and December 2012 were identified and
their medical records reviewed. Data pertaining to patient
demographics, symptoms at diagnosis, atopic history,
endoscopic and histologic findings, results of allergy
testing (skin prick, patch and immunoCAP) and treatment
outcomes were extracted.
Results
A total of 96 cases were identified. The median age at
diagnosis was 13.2 years (IQR=8.6-15.7), and 72 of the
identified cases were male (74.2%). Seventy-four of
91 (81%) and 62 of 79 (78%) patients with data available
reported a history of personal and family atopy, respec-
tively. Six patients (7%) had a first degree family member
diagnosed with EoE. Patients who reported a history of
food allergy were significantly more likely to present with
a food bolus impaction at diagnosis (p=0.035, OR=3.056).
Sixty-nine patients underwent allergy testing as part of a
standard EoE workup, of which, 60 (87.0%) had a positive
test result. Ten (14.5%) patients who had identifiable
allergies were positive only to environmental allergens.
The top identified food and environmental allergens were
recorded by allergy test type (Figs 1, 2, 3, 4).
Conclusions
Pediatric EoE is considered to be an allergic disease with
both environmental and food allergen triggers in many
patients. A majority of patients present with a history of
Figure 2 N=69 underwent skin prick testing
Figure 3 N=35 underwent patch testing
Tutelman et al. Allergy, Asthma & Clinical Immunology 2014, 10(Suppl 1):A28
http://www.aacijournal.com/content/10/S1/A28
Page 2 of 3
atopy and show positive allergy test results to both
foods and aeroallergens. Both environmental and food
allergen elimination should be considered a part of a
therapeutic program. Identification of offending aller-
gens by allergy skin and patch testing can be an impor-
tant factor in guiding clinical decision making.
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Figure 4 N=14 underwent ImmunoCAP testing.
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